Bermel RA - Search Results

1

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

Bermel RA, Puli SR, Rudick RA, Weinstock-Guttman B, Fisher E, Munschauer FE 3rd, Bakshi R. Bermel RA, et al. Arch Neurol. 2005 Sep;62(9):1371-6. doi: 10.1001/archneur.62.9.1371. Arch Neurol. 2005. PMID: 16157744 Free PMC article.

2

A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis.

Jalaleddini K, Bermel RA, Talente B, Weinstein D, Qureshi F, Rasmussen M, Menon S, Amarapala M, Jordan K, Ghoreyshi A, McCurdy S, Edgeworth M. Jalaleddini K, et al. Among authors: bermel ra. Mult Scler. 2024 Mar;30(3):432-442. doi: 10.1177/13524585241227372. Epub 2024 Feb 19. Mult Scler. 2024. PMID: 38374525

3

A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis.

Airas L, Bermel RA, Chitnis T, Hartung HP, Nakahara J, Stuve O, Williams MJ, Kieseier BC, Wiendl H. Airas L, et al. Among authors: bermel ra. Ther Adv Neurol Disord. 2024 Apr 17;17:17562864241233041. doi: 10.1177/17562864241233041. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 38638671 Free PMC article. Review.

4

Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings.

Bakshi R, Benedict RH, Bermel RA, Jacobs L. Bakshi R, et al. Among authors: bermel ra. J Neuroimaging. 2001 Apr;11(2):129-36. doi: 10.1111/j.1552-6569.2001.tb00022.x. J Neuroimaging. 2001. PMID: 11296581

5

T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.

Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ, Jacobs L. Bakshi R, et al. Among authors: bermel ra. Arch Neurol. 2002 Jan;59(1):62-8. doi: 10.1001/archneur.59.1.62. Arch Neurol. 2002. PMID: 11790232

6

Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis.

Bermel RA, Bakshi R, Tjoa C, Puli SR, Jacobs L. Bermel RA, et al. Arch Neurol. 2002 Feb;59(2):275-80. doi: 10.1001/archneur.59.2.275. Arch Neurol. 2002. PMID: 11843699

7

Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study.

Bermel RA, Innus MD, Tjoa CW, Bakshi R. Bermel RA, et al. Neuroreport. 2003 Mar 3;14(3):335-9. doi: 10.1097/00001756-200303030-00008. Neuroreport. 2003. PMID: 12634479

8

A semiautomated measure of whole-brain atrophy in multiple sclerosis.

Bermel RA, Sharma J, Tjoa CW, Puli SR, Bakshi R. Bermel RA, et al. J Neurol Sci. 2003 Apr 15;208(1-2):57-65. doi: 10.1016/s0022-510x(02)00425-2. J Neurol Sci. 2003. PMID: 12639726

9

Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.

Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA. Bakshi R, et al. Among authors: bermel ra. J Neuroimaging. 2005;15(4 Suppl):30S-45S. doi: 10.1177/1051228405283901. J Neuroimaging. 2005. PMID: 16385017 Review.

10

The measurement and clinical relevance of brain atrophy in multiple sclerosis.

Bermel RA, Bakshi R. Bermel RA, et al. Lancet Neurol. 2006 Feb;5(2):158-70. doi: 10.1016/S1474-4422(06)70349-0. Lancet Neurol. 2006. PMID: 16426992 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters